2018
DOI: 10.3324/haematol.2018.188441
|View full text |Cite
|
Sign up to set email alerts
|

Successful treatment of disseminated Rosai-Dorfman disease with siltuximab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(6 citation statements)
references
References 12 publications
0
6
0
Order By: Relevance
“…It is worth noting that in contrast to Langerhans cell histiocytosis, these cells are negative for CD1a and CD207 markers 4 . Although extranodal involvement in RDD is common and may occur in more than 40% of patients without lymphadenopathy occurrence, 6 intra‐abdominal involvement is uncommon with an incidence of 4% 9 . Of note, the GI manifestation mostly affects middle‐aged females 10 .…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…It is worth noting that in contrast to Langerhans cell histiocytosis, these cells are negative for CD1a and CD207 markers 4 . Although extranodal involvement in RDD is common and may occur in more than 40% of patients without lymphadenopathy occurrence, 6 intra‐abdominal involvement is uncommon with an incidence of 4% 9 . Of note, the GI manifestation mostly affects middle‐aged females 10 .…”
Section: Discussionmentioning
confidence: 99%
“…In general, RDD is defined as a self‐limited disease; however, it can be also permanent or seldom a life‐threatening condition. 6 The diagnosis of RDD mainly relies on histology and immunohistochemistry (IHC) assessments along with diagnostic imaging. IHC staining of the histiocytes are positive for S‐100, CD68, and CD163, while CD1a + cells are detected for Langerhans cell histiocytosis.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations